VBI Vaccines
VBIV
#10518
Rank
S$2.36 M
Marketcap
S$0.08245
Share price
0.00%
Change (1 day)
-89.88%
Change (1 year)

EPS for VBI Vaccines (VBIV)

EPS in 2024 (TTM): S-$13.65

According to VBI Vaccines 's latest financial reports the company's current EPS (TTM) is S-$12.80. In 2022 the company made an earnings per share (EPS) of S-$16.67 a decrease over its 2021 EPS that were of S-$10.23.

EPS history for VBI Vaccines from 1997 to 2024

Annual EPS

Year EPS Change
2024 (TTM)S-$13.65
2022S-$16.6762.96%
2021S-$10.2328.57%
2020S-$7.95-54.35%
2019S-$17.42-52.58%
2018S-$36.7410.23%
2017S-$33.3314.29%
2016S-$29.17-62.8%
2015S-$78.4190.68%
2014S-$41.12-7.95%
2013S-$44.67-57.97%
2012S-$106.30-78%
2011S-$483.253151.47%
2010S-$14.8623.87%
2009S-$12.00-18.48%
2008S-$14.7212.08%
2007S-$13.13-49.47%
2006S-$25.99
2005N/A-100%
2004S-$11.5511.94%
2003S-$10.32-81.89%
2002S-$57.00196.44%
2001S-$19.2384.33%
2000S-$10.43-65.37%
1999S-$30.12-29.45%
1998S-$42.6929.61%
1997S-$32.94

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Onconova Therapeutics
ONTX
S-$1.20-90.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Curis
CRIS
S-$4.63-63.81%๐Ÿ‡บ๐Ÿ‡ธ USA
Myriad Genetics
MYGN
S-$5.47-57.30%๐Ÿ‡บ๐Ÿ‡ธ USA